6PHQ
Crystal structure of glucagon analog fully composed of D-amino acids with 4-bromo-D-phenylalanine substitutions at position 6 and 22 in space group I41 at 1.1 A resolution
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 4.2.2 |
Synchrotron site | ALS |
Beamline | 4.2.2 |
Temperature [K] | 100 |
Detector technology | CMOS |
Collection date | 2019-03-16 |
Detector | RDI CMOS_8M |
Wavelength(s) | 0.9184 |
Spacegroup name | I 41 |
Unit cell lengths | 41.770, 41.770, 30.439 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 20.880 - 1.320 |
R-factor | 0.2009 |
Rwork | 0.199 |
R-free | 0.24730 |
Structure solution method | SAD |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | PHENIX ((1.15_3459: ???)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 20.880 | 1.450 |
High resolution limit [Å] | 1.320 | 1.320 |
Rmeas | 0.063 | 1.459 |
Rpim | 0.016 | 0.522 |
Number of reflections | 6050 | 1512 |
<I/σ(I)> | 26.8 | 1.7 |
Completeness [%] | 98.0 | 100 |
Redundancy | 22.6 | 14.6 |
CC(1/2) | 0.999 | 0.737 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 293 | 0.2 M sodium chloride, 20% PEG3350 |